| Boynton Beach Rehabilitation Center | |
| 9600 Lawrence Rd, Boynton Beach, Florida 33436 | |
| (561) 740-4100 | |
| Name | Boynton Beach Rehabilitation Center |
|---|---|
| Location | 9600 Lawrence Rd, Boynton Beach, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 168 |
| Occupancy Rate | 66.85% |
| Medicare ID (CCN) | 105837 |
| Legal Business Name | Sovereign Healthcare Of Boynton Beach Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1396732012 |
| Organization Name | SOVEREIGN HEALTHCARE OF BOYNTON BEACH, LLC |
| Doing Business As | BOYNTON BEACH REHABILITATION CENTER |
| Address | 9600 Lawrence Rd, Boynton Beach, FL 33436 |
| Phone Number | 561-740-4100 |
News Archive
Little is known about the long-term health of survivors of childhood cancers that affect vision, but two new studies provide valuable insights that could impact patient care and follow-up. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A unique research project into the highly sensitive problem of domestic violence towards older women is being carried out by researchers from The University of Nottingham's Division of Nursing.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
By studying children's activities over 24-hour periods, Dr. Elizabeth Vandewater and her colleagues provide evidence for the first time that supports the American Academy of Pediatrics (AAP) television viewing recommendations.
OPKO Health, Inc. today announced that it has completed the acquisition of rolapitant and a related compound from Schering Corporation, a subsidiary of Merck & Co., Inc. ("Schering").
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Little is known about the long-term health of survivors of childhood cancers that affect vision, but two new studies provide valuable insights that could impact patient care and follow-up. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A unique research project into the highly sensitive problem of domestic violence towards older women is being carried out by researchers from The University of Nottingham's Division of Nursing.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
By studying children's activities over 24-hour periods, Dr. Elizabeth Vandewater and her colleagues provide evidence for the first time that supports the American Academy of Pediatrics (AAP) television viewing recommendations.
OPKO Health, Inc. today announced that it has completed the acquisition of rolapitant and a related compound from Schering Corporation, a subsidiary of Merck & Co., Inc. ("Schering").
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 6.56 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.11 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 59.56 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.31 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 6.59 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.19 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.63 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.01 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.06 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 7.97 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.76 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.45 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.47 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 93.65 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.84 | 82.93 |
News Archive
Little is known about the long-term health of survivors of childhood cancers that affect vision, but two new studies provide valuable insights that could impact patient care and follow-up. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A unique research project into the highly sensitive problem of domestic violence towards older women is being carried out by researchers from The University of Nottingham's Division of Nursing.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
By studying children's activities over 24-hour periods, Dr. Elizabeth Vandewater and her colleagues provide evidence for the first time that supports the American Academy of Pediatrics (AAP) television viewing recommendations.
OPKO Health, Inc. today announced that it has completed the acquisition of rolapitant and a related compound from Schering Corporation, a subsidiary of Merck & Co., Inc. ("Schering").
› Verified 6 days ago
Boulevard Rehabilitation Center Location: 2839 S Seacrest Blvd, Boynton Beach, Florida 33435 Phone: (561) 732-2464 | |
Ventura Health And Rehabilitation Center Location: 7900 Venture Center Way, Boynton Beach, Florida 33437 Phone: (561) 736-6000 | |
Manorcare Health Services Boynton Beach Location: 3001 South Congress Avenue, Boynton Beach, Florida 33426 Phone: (561) 737-5600 | |
Heartland Health Care Center Boynton Beach Location: 3600 Old Boynton Road, Boynton Beach, Florida 33436 Phone: (561) 736-9992 | |
Boynton Beach Rehabilitation Center Location: 9600 Lawrence Rd, Boynton Beach, Florida 33436 Phone: (561) 740-4100 | |
Barrington Terrace Of Boynton Beach Location: 1425 S Congress Ave, Boynton Beach, Florida 33426 Phone: (561) 369-7919 |